Journal
NEUROBIOLOGY OF AGING
Volume 33, Issue 12, Pages 2723-2732Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2012.01.014
Keywords
Apolipoprotein E; Late-onset Alzheimer's disease; Magnetic resonance imaging; Voxel-based morphometry; Multivariate analysis; Gray matter volume
Categories
Funding
- Alzheimer's Association [IIRG-02-3784]
- National Institute of Mental Health [MH57899]
- National Institute on Aging [AG025526, AG19610, AG031581]
- state of Arizona
- Arizona Department of Health Service
- Arizona Advanced Research Institute for Biomedical Imaging
- Evelyn F. McKnight Brain Institute
Ask authors/readers for more resources
The apolipoprotein E (APOE) epsilon 4 allele increases the risk for late-onset Alzheimer's disease (AD) and age-related cognitive decline. We investigated whether epsilon 4 carriers show reductions in gray matter volume compared with epsilon 4 non-carriers decades before the potential onset of AD dementia or healthy cognitive aging. Fourteen cognitively normal epsilon 4 carriers, aged 26 to 45 years, were compared with 10 age-matched, epsilon 4 non-carriers using T1-weighted volumetric magnetic resonance imaging (MRI) scans. All had reported first-or second-degree family histories of dementia. Group differences in gray matter were tested using voxel-based morphometry (VBM) and a multivariate model of regional covariance, the Scaled Subprofile Model (SSM). A combination of the first two SSM MRI gray matter patterns distinguished the APOE epsilon 4 carriers from non-carriers. This combined pattern showed gray matter reductions in bilateral dorsolateral and medial frontal, anterior cingulate, parietal, and lateral temporal cortices with covarying relative increases in cerebellum, occipital, fusiform, and hippocampal regions. With these gray matter differences occurring decades before the potential onset of dementia or cognitive aging, the results suggest longstanding, gene-associated differences in brain morphology that may lead to preferential vulnerability for the later effects of late-onset AD or healthy brain aging. (C) 2012 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available